Cue Health, Inc.

As of August 10, 2022, Cue Health, Inc. is considered overvalued and risky due to significant financial challenges, including a P/E ratio of 0.00, an EV to EBITDA ratio of 0.19, a ROE of -116.50%, and a 100% stock decline over the past year, contrasting sharply with the S&P 500's 10.26% return.

As of July 8, 2024, the market trend is mildly bearish, indicated by daily moving averages and monthly RSI, despite some mildly bullish signals from the weekly MACD and KST, suggesting caution due to the overall bearish sentiment.

As of Jun 16, Cue Health, Inc. has a market capitalization of 0.00, classifying it as a Micro Cap company, with net sales of 56.23 million and a net profit of -328.78 million over the latest four quarters. As of Dec 23, shareholder's funds are 250.25 million and total assets are 339.79 million.